Cargando…
Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs
MicroRNAs (miRs, miRNAs) are regulatory small noncoding RNAs, with their roles already confirmed to be important for post-transcriptional regulation of gene expression affecting cell physiology and disease development. Upregulation of a cancer-causing miRNA, known as oncogenic miRNA, has been found...
Autores principales: | Nguyen, Dinh-Duc, Chang, Suhwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796015/ https://www.ncbi.nlm.nih.gov/pubmed/29280958 http://dx.doi.org/10.3390/ijms19010065 |
Ejemplares similares
-
Simultaneous inhibition of multiple oncogenic miRNAs by a multi-potent microRNA sponge
por: Jung, Jaeyun, et al.
Publicado: (2015) -
Epigenetic control of an oncogenic microRNA, miR-155, by BRCA1
por: Chang, Suhwan, et al.
Publicado: (2012) -
microRNAs as Novel Therapeutics in Cancer
por: Romano, Giulia, et al.
Publicado: (2021) -
Oncogenic MicroRNAs: Key Players in Malignant Transformation
por: Frixa, Tania, et al.
Publicado: (2015) -
Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents
por: Khoshnam, Seyed Esmaeil, et al.
Publicado: (2017)